company background image
PTKF.F logo

Kalbe Farma OTCPK:PTKF.F Stock Report

Last Price

US$0.09

Market Cap

US$4.4b

7D

0%

1Y

-36.6%

Updated

27 Mar, 2024

Data

Company Financials +

PTKF.F Stock Overview

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia.

PTKF.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends3/6

PT Kalbe Farma Tbk. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kalbe Farma
Historical stock prices
Current Share PriceRp0.09
52 Week HighRp0.15
52 Week LowRp0.09
Beta0.19
1 Month Change-9.18%
3 Month Change-12.15%
1 Year Change-36.58%
3 Year Change-10.00%
5 Year Changen/a
Change since IPO28.57%

Recent News & Updates

Recent updates

Shareholder Returns

PTKF.FUS PharmaceuticalsUS Market
7D0%-0.2%0.6%
1Y-36.6%23.9%29.5%

Return vs Industry: PTKF.F underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: PTKF.F underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is PTKF.F's price volatile compared to industry and market?
PTKF.F volatility
PTKF.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PTKF.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PTKF.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
196613,134- Vidjongtiushttps://www.kalbe.co.id

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals and Distribution; and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.

PT Kalbe Farma Tbk. Fundamentals Summary

How do Kalbe Farma's earnings and revenue compare to its market cap?
PTKF.F fundamental statistics
Market capUS$4.41b
Earnings (TTM)US$187.44m
Revenue (TTM)US$1.92b

23.5x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PTKF.F income statement (TTM)
RevenueRp30.31t
Cost of RevenueRp18.70t
Gross ProfitRp11.61t
Other ExpensesRp8.65t
EarningsRp2.96t

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)64.03
Gross Margin38.31%
Net Profit Margin9.77%
Debt/Equity Ratio4.7%

How did PTKF.F perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

60%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.